Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TERBINAFINE HCL 250 MG TABLET

Terbinafine Tablets 250 mg
$0.1513per EA

Strength

250 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097073102

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/23/2025

Active Ingredients

TERBINAFINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077137

On Market Since

1/8/2021

Pharmacological Classes

Allylamine Antifungal
Allylamine

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-7.1%

5Y

-11.8%

All

-8.6%

Generic Alternatives

1 alternative • Same active ingredient

TERBINAFINE HCL 250 MG TABLET
Generic
69097073107•Cipla USA Inc.
$0.1544
+2% more

Related Drugs

Same classification

TERBINAFINE HCL 250 MG TABLET
Generic
16714079501•NorthStar Rx LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
16714079502•NorthStar Rx LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
51991052601•Breckenridge Pharmaceutical Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
62135057230•Chartwell RX LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
62135057290•Chartwell RX LLC
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
65862007930•Aurobindo Pharma Limited
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69097085902•Cipla USA Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69097085907•Cipla USA Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69452035113•Bionpharma Inc.
$0.1409
per EA
TERBINAFINE HCL 250 MG TABLET
Generic
69452035120•Bionpharma Inc.
$0.1409
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy